ArticleInternational journal for equity in health2008
What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries.
Article in International journal for equity in health, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers, 6 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
38 citing papers in PubMed, 6 syntheses or guidelines pooled it.
- A systematic umbrella review of the association of prescription drug insurance and cost-sharing with drug use, health services use, and health.BMC health services research · 2022Pooled it
- Financial arrangements for health systems in low-income countries: an overview of systematic reviews.The Cochrane database of systematic reviews · 2017Pooled it
- The efficacy of psychotherapy, pharmacotherapy and their combination on functioning and quality of life in depression: a meta-analysis.Psychological medicine · 2017Pooled it
- How does copayment for health care services affect demand, health and redistribution? A systematic review of the empirical evidence from 1990 to 2011.The European journal of health economics : HEPAC : health economics in prevention and care · 2014Pooled it
- The influence of health systems on hypertension awareness, treatment, and control: a systematic literature review.PLoS medicine · 2013Pooled it
- Pooled it
- What is in your wallet? A cluster randomized trial of the effects of showing comparative patient out-of-pocket costs on primary care prescribing for uncomplicated hypertension.Implementation science : IS · 2018Trial
- How lack of subsidized prescription drug coverage affects medication use by low-income Medicare beneficiaries.Health affairs scholar · 2026Article
- A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids.Cardiovascular drugs and therapy · 2025Review
- Opioid deprescribing: rethinking policies to facilitate better patient outcomes.Pain management · 2025Review
- Evaluation of Prescription Practices Using WHO/INRUD Indicators and Determinants of Polypharmacy at a Kenyan County Referral Hospital.Advances in pharmacological and pharmaceutical sciences · 2025Article
- Improving antibiotic prescribing - Recommendations for funding and pricing policies to enhance use of point-of-care tests.Health policy OPEN · 2024Article
- Prediction of COVID-19 patients' participation in financing informal care using machine learning methods: willingness to pay and willingness to accept approaches.BMC health services research · 2024Article
- Agenda setting for essential medicines policy in sub-Saharan Africa: a retrospective policy analysis using Kingdon's multiple streams model.Health research policy and systems · 2021Review
- The unequal effects of austerity measures between income-groups on the access to healthcare: a quasi-experimental approach.International journal for equity in health · 2021Article
- Impact of the economic crisis on household health expenditure in Greece: an interrupted time series analysis.BMJ open · 2020Article
- Unfilled Prescriptions of Medicare Beneficiaries: Prevalence, Reasons, and Types of Medicines Prescribed.Journal of managed care & specialty pharmacy · 2020Article
- The impact of prescription drug co-payments for publicly insured families.The European journal of health economics : HEPAC : health economics in prevention and care · 2020Article
- Affordable and equitable access to subsidised outpatient medicines? Analysis of co-payments under the Additional Drug Package in Kyrgyzstan.International journal for equity in health · 2019Article
- Reduced user fees for antibiotics under age 5 in Hungary: Effect on antibiotic use and imbalances in the implementation.PloS one · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
As pharmaceutical expenditure continues to rise, third-party payers in most high-income countries have increasingly shifted the burden of payment for prescription drugs to patients. A large body of literature has examined the relationship between prescription charges and outcomes such as expenditure, use, and health, but few reviews explicitly link cost sharing for prescription drugs to efficiency and equity. This article reviews 173 studies from 15 high-income countries and discusses their implications for important issues sometimes ignored in the literature; in particular, the extent to which prescription charges contain health care costs and enhance efficiency without lowering equity of access to care.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.